/ Published in 2025, Publication

Durability of immunogenicity at 5 years after a single dose of human papillomavirus vaccine compared with two doses in Tanzanian girls aged 9-14 years: results of the long-term extension of the DoRIS randomised trial.

Durability of immunogenicity at 5 years after a single dose of human papillomavirus vaccine compared with two doses in Tanzanian girls aged 9-14 years: results of the long-term extension of the DoRIS randomised trial.
Watson-Jones D, Changalucha J, Maxwell C, Whitworth H, Mutani P, Kemp TJ, Kamala B, Indangasi J, Constantine G, Hashim R, Mwanzalima D, Wiggins R, Mmbando D, Connor N, Pavon MA, Lowe B, Kapiga S, Mayaud P, de Sanjosé S, Dillner J, Hayes RJ, Lacey CJ, Pinto L, Baisley K.
Lancet Glob Health. 2025 Feb;13(2):e319-e328.
DOI: 10.1016/S2214-109X(24)00477-7.
PMID: 39890232;
PMCID: PMC11783036.

What you can read next

The HIV prevention cascade: integrating theories of epidemiological, behavioural, and social science into programme design and monitoring.
High prevalence of hypertension and of risk factors for non-communicable diseases (NCDs)
Unmet menstrual needs and psychosocial well-being among schoolgirls in Northern Tanzania: baseline results from the PASS MHW study.